RefaMetinib (R enantioMer);RefaMetinib (RDEA-119, BAY 86-9766);N-[3,4-Difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl]-1-[(2R)-2,3-dihydroxypropyl]cyclopropanesulfonamide;Refametinib (BAY 869766) R enantiomer;RDEA119; RDEA 119; BAY 86-9766; BAY 869766; BAY869766;RDEA119 R enantiomer;BAY 869766 R enantiomer;Cyclopropanesulfonamide, N-[3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl]-1-[(2R)-2,3-dihydroxypropyl]-